Alan Urban
Chief Financial Officer at GT Biopharma.
Earliest Form D on file: Mar 2025
3 filings at 1 company
GT Biopharma
Biotech, San Francisco CA
Chief Financial Officer · signer
- Signed
- Named
- Size is amount sold, up to $30M
Filings
3- May 28, 2025
Equity, signed · Form D
$0
of $20M
- May 27, 2025
Equity, option to acquire, security to be acquired, signed · Form D
$5.95M
of $5.95M
May 27, 2025Equity, option to acquire, security to be acquired
Signed as Chief Financial Officer
$5.95M
$5.95M
- Mar 7, 2025
Equity, option to acquire, security to be acquired, signed · Form D
$1.3M
of $1.3M
Mar 7, 2025Equity, option to acquire, security to be acquired
Signed as Chief Financial Officer
$1.3M
$1.3M
Network
At GT Biopharma
6 people- Together on 3 filings
Executive Officer, Director
- Together on 3 filings
Director
- Together on 2 filings
Director
- Together on 2 filings
Director
- Together on 1 filing
Director
- Together on 1 filing
Director